← Leaderboards
Anthony Rosenzweig
University Of Michigan At Ann Arbor
$35,493,023
Attributed
$39,042,479
Total exposure
19
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.6M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$39,042,479 · 19
By mechanism
R01$21,345,845 · 12
T32$7,840,240 · 2
R35$4,593,336 · 1
UH3$3,208,055 · 1
UH2$1,074,150 · 1
R21$980,853 · 2
Top collaborators
- Saumya Das11 shared
- Raymond Y Kwong9 shared
- Marc S Sabatine9 shared
- Alan C Rigby2 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Su-Hua Sha$5,164,831
Others in their field
Top investigators on “Cardiac Myocytes”
- Joseph C Wu · Stanford University$53,447,011
- Donald M Bers · Cincinnati Childrens Hosp Med Ctr$50,074,770
- Jeffery D Molkentin · Cincinnati Childrens Hosp Med Ctr$40,971,477
- Piero Anversa · New York Medical College$40,584,258
- Junichi Sadoshima · Rutgers Biomedical And Health Sciences$34,907,735
- Steven R Houser · Johns Hopkins University$33,565,081
Research focus
Cardiac MyocytesHeart FailureCardiacIn VitroHeartPathway InteractionsIn VivoPhenotypeMorbidity - Disease RateAnimal ModelResearch PersonnelInvestigationBaseCardiovascular SystemLoss Of FunctionApoptosisResponseTherapeutic TargetGeneticCellsPlayInsightMediatingFoundations
Grant awards (93)
Understanding the Cardiac Benefits of Exercise at the Cellular and Molecular Level$773,364
R35 · FY2025 · HL · contact PI
Understanding the Cardiac Benefits of Exercise at the Cellular and Molecular Level$757,897
R35 · FY2024 · HL · contact PI
Understanding the Cardiac Benefits of Exercise at the Cellular and Molecular Level$847,474
R35 · FY2023 · HL · contact PI
Role of Activin Type II receptor signaling in age-related heart failure$558,257
R01 · FY2023 · AG · contact PI
Role of Activin Type II receptor signaling in age-related heart failure$1
R01 · FY2023 · AG · contact PI
Understanding the Cardiac Benefits of Exercise at the Cellular and Molecular Level$909,471
R35 · FY2022 · HL · contact PI
Role of Activin Type II receptor signaling in age-related heart failure$559,281
R01 · FY2022 · AG · contact PI
Integrated, Multidisciplinary Training in Cardiovascular Research$430,525
T32 · FY2022 · HL · contact PI
Understanding the Cardiac Benefits of Exercise at the Cellular and Molecular Level$395,659
R35 · FY2022 · HL · contact PI
Understanding the Cardiac Benefits of Exercise at the Cellular and Molecular Level$909,471
R35 · FY2021 · HL · contact PI
Role of Activin Type II receptor signaling in age-related heart failure$566,473
R01 · FY2021 · AG · contact PI
Integrated, Multidisciplinary Training in Cardiovascular Research$519,358
T32 · FY2021 · HL · contact PI
Integrated, Multidisciplinary Training in Cardiovascular Research$700,892
T32 · FY2020 · HL · contact PI
Role of Activin Type II receptor signaling in age-related heart failure$519,787
R01 · FY2020 · AG · contact PI
Role of miR-222 in pathological hypertrophy and heart failure$412,052
R01 · FY2020 · HL · contact PI
Discovery and characterization of lncRNAs involved in cardiac exercise phenotypes$399,600
R01 · FY2020 · HL · contact PI
Role of Activin Type II receptor signaling in age-related heart failure$209,654
R01 · FY2020 · AG · contact PI
Integrated, Multidisciplinary Training in Cardiovascular Research$646,321
T32 · FY2019 · HL · contact PI
Role of Activin Type II receptor signaling in age-related heart failure$594,143
R01 · FY2019 · AG · contact PI
Role of miR-222 in pathological hypertrophy and heart failure$412,017
R01 · FY2019 · HL · contact PI
Integrated, Multidisciplinary Training in Cardiovascular Research$646,715
T32 · FY2018 · HL · contact PI
Does Exercise Induce Cardiomyogenesis?$426,250
R01 · FY2018 · HL · contact PI
Role of miR-222 in pathological hypertrophy and heart failure$411,982
R01 · FY2018 · HL · contact PI
Plasma miRNA predictors of adverse mechanical and electrical remodeling after MI$1,000,000
UH3 · FY2017 · TR
Role of miR-222 in pathological hypertrophy and heart failure$429,699
R01 · FY2017 · HL · contact PI
Does Exercise Induce Cardiomyogenesis?$426,250
R01 · FY2017 · HL · contact PI
Cell & Molecular Training for Cardiovascular Biology$403,986
T32 · FY2017 · HL · contact PI
Multi-group collaborative proposal: Diversity and function of prevalent uncharacterized exRNA species from tissue and biofluid$77,805
UH3 · FY2017 · TR
Plasma miRNA predictors of adverse mechanical and electrical remodeling after MI$1,000,000
UH3 · FY2016 · TR
Cell & Molecular Training for Cardiovascular Biology$703,027
T32 · FY2016 · HL · contact PI
Plasma miRNA predictors of adverse mechanical and electrical remodeling after MI$43,250
UH3 · FY2016 · TR
Plasma miRNA predictors of adverse mechanical and electrical remodeling after MI$1,000,000
UH3 · FY2015 · TR
Cell & Molecular Training for Cardiovascular Biology$705,887
T32 · FY2015 · HL · contact PI
The role of C/EBPbeta and CITED4 in the heart$348,000
R01 · FY2015 · HL · contact PI
Does Exercise Induce Cardiomyogenesis?$271,406
R01 · FY2015 · HL · contact PI
Does Exercise Induce Cardiomyogenesis?$152,661
R01 · FY2015 · HL · contact PI
Plasma miRNA predictors of adverse mechanical and electrical remodeling after MI$87,000
UH3 · FY2015 · TR
The role of C/EBPbeta and CITED4 in the heart$80,475
R01 · FY2015 · HL · contact PI
Plasma miRNA predictors of adverse mechanical and electrical remodeling after MI$500,000
UH2 · FY2014 · TR
Does Exercise Induce Cardiomyogenesis?$448,574
R01 · FY2014 · HL · contact PI
Training Program in Cardiovascular Research$433,545
T32 · FY2014 · HL · contact PI
The role of C/EBP?? and CITED4 in the heart$426,300
R01 · FY2014 · HL · contact PI
Micro-RNA regulation of the cardiac exercise response$213,150
R21 · FY2014 · HL · contact PI
Optimization of biofluid ex-RNA isolation and characterization.$74,150
UH2 · FY2014 · TR
Plasma miRNA predictors of adverse mechanical and electrical remodeling after MI$500,000
UH2 · FY2013 · TR
The role of C/EBP?? and CITED4 in the heart$414,120
R01 · FY2013 · HL · contact PI
Role of serum- and glucocorticoid-regulated kinase-1 in electrical remodeling$409,979
R01 · FY2013 · HL · contact PI
Training Program in Cardiovascular Research$364,644
T32 · FY2013 · HL · contact PI
Micro-RNA regulation of the cardiac exercise response$261,000
R21 · FY2013 · HL · contact PI
Training Program in Cardiovascular Research$466,081
T32 · FY2012 · HL · contact PI
The role of C/EBP?? and CITED4 in the heart$435,000
R01 · FY2012 · HL · contact PI
Role of serum- and glucocorticoid-regulated kinase-1 in electrical remodeling$430,650
R01 · FY2012 · HL · contact PI
Role of serum- and glucocorticoid-regulated kinase-1 in electrical remodeling$435,000
R01 · FY2011 · HL · contact PI
The role of C/EBP?? and CITED4 in the heart$435,000
R01 · FY2011 · HL · contact PI
Training Program in Cardiovascular Research$408,888
T32 · FY2011 · HL · contact PI
Computational discovery of SGK1 inhibitors for the treatment of heart disease$289,359
R21 · FY2011 · HL · contact PI
Role of serum- and glucocorticoid-regulated kinase-1 in electrical remodeling$434,063
R01 · FY2010 · HL · contact PI
Role of Integrin-Linked Kinase in Heart Failure and Ischemic Injury$425,000
R01 · FY2010 · HL · contact PI
Training Program in Cardiovascular Research$352,344
T32 · FY2010 · HL · contact PI
Computational discovery of SGK1 inhibitors for the treatment of heart disease$217,344
R21 · FY2010 · HL · contact PI
Role of Integrin-Linked Kinase in Heart Failure and Ischemic Injury$425,000
R01 · FY2009 · HL · contact PI
Cardiovascular Research Training Program$421,710
T32 · FY2009 · HL · contact PI
Role of Integrin-Linked Kinase in Heart Failure and Ischemic Injury$425,000
R01 · FY2008 · HL · contact PI
Cardiovascular Research Training Program$418,159
T32 · FY2008 · HL · contact PI
Signaling mechanisms of cardioprotection and remodeling$402,977
R01 · FY2008 · HL · contact PI
Role of FADD signaling in ischemic cardiac injury$322,381
R01 · FY2008 · HL · contact PI
Role of Integrin-Linked Kinase in Heart Failure and Ischemic Injury$425,000
R01 · FY2007 · HL · contact PI
Signaling mechanisms of cardioprotection and remodeling$402,977
R01 · FY2007 · HL · contact PI
Role of FADD signaling in ischemic cardiac injury$322,381
R01 · FY2007 · HL · contact PI
Cardiovascular Research Training Program$218,158
T32 · FY2007 · HL · contact PI
Role of myostatin in cardiac hypertrophy and failure$454,559
R01 · FY2006 · HL · contact PI
Signaling mechanisms of cardioprotection and remodeling$415,013
R01 · FY2006 · HL · contact PI
Role of FADD signaling in ischemic cardiac injury$180,000
R01 · FY2006 · HL · contact PI
Role of FADD signaling in ischemic cardiac injury$159,725
R01 · FY2006 · HL · contact PI
Role of myostatin in cardiac hypertrophy and failure$457,364
R01 · FY2005 · HL
Signaling mechanisms of cardioprotection and remodeling$427,217
R01 · FY2005 · HL
Role of FADD signaling in ischemic cardiac injury$347,900
R01 · FY2005 · HL
Effects of Akt activation in ischemia-reperfusion injury$309,863
R01 · FY2005 · HL
Effects of Akt activation in ischemia-reperfusion injury$116,523
R01 · FY2005 · HL
Role of myostatin in cardiac hypertrophy and failure$445,193
R01 · FY2004 · HL
Role of FADD signaling in ischemic cardiac injury$344,613
R01 · FY2004 · HL
Effects of Akt activation in ischemia-reperfusion injury$339,886
R01 · FY2004 · HL
Role of myostatin in cardiac hypertrophy and failure$427,230
R01 · FY2003 · HL
Effects of Akt activation in ischemia-reperfusion injury$339,886
R01 · FY2003 · HL
SIGNALING PATHWAYS, CARDIAC APOPTOSIS, AND HEART FAILURE$427,500
R01 · FY2002 · HL
Effects of Akt activation in ischemia-reperfusion injury$364,886
R01 · FY2002 · HL
SIGNALING PATHWAYS, CARDIAC APOPTOSIS, AND HEART FAILURE$427,500
R01 · FY2001 · HL
IGF-I RECEPTOR SIGNALING AND CARDIOCYTE APOPTOSIS$280,189
R01 · FY2001 · HL
ROLE OF MONONUCLEAR LEUKOCYTES IN GRAFT ARTERIOSCLEROSIS$234,986
R01 · FY2001 · AI
SIGNALING PATHWAYS, CARDIAC APOPTOSIS, AND HEART FAILURE$427,500
R01 · FY2000 · HL
IGF-I RECEPTOR SIGNALING AND CARDIOCYTE APOPTOSIS$272,027
R01 · FY2000 · HL
ROLE OF MONONUCLEAR LEUKOCYTES IN GRAFT ARTERIOSCLEROSIS$228,145
R01 · FY2000 · AI
VCAM-1 AND CHEMOKINES AND MONOCYTE RECRUITMENT$120,750
R01 · FY2000 · HL